01 Increasing Adoption of Latex-Free Rubber Products A significant market trend is the increasing adoption of latex-free rubber products. Latex allergies have become a growing concern in healthcare, leading to a shift towards synthetic rubber materials such as nitrile and silicone. These materials offer similar elasticity and durability without the risk of allergic reactions. For instance, a study published by the National Center for Biotechnology Information (NCBI) in 2022 highlighted that over 8% of healthcare workers suffer from latex allergies, prompting manufacturers to innovate with alternative materials. This market trend is further driven by stringent regulations and guidelines issued by health authorities like the FDA and the European Medicines Agency, mandating the use of non-latex products to ensure patient safety. Consequently, this shift is expected to significantly influence the market size, driving increased adoption of synthetic rubber-based medical products.
June 2026 Teleflex launched the Arrow® ErgoPack™ PTA Balloon Catheter System, expanding its portfolio of balloon-based interventional medical devices.
April 2026 Boston Scientific received U.S. FDA approval for an expanded indication of its AGENT™ Drug-Coated Balloon, strengthening its interventional balloon product portfolio.
September 2025 Becton, Dickinson and Company (BD) expanded manufacturing capacity for interventional balloon catheter components to support growing demand for minimally invasive procedures.
July 2025 Tokai Medical Products introduced a next-generation PTA balloon catheter featuring enhanced balloon durability and flexibility for peripheral vascular interventions.